Podcast: Play in new window | Download

Subscribe: TuneIn | RSS

We’re excited to bring you the first of two episodes about the drug development process we recorded LIVE at Reata Pharmaceuticals headquarters in Irving, TX. In this episode, we talk to Warren Huff, the founder and CEO, and Dr. Collin Meyer, Chief Medical Officer.

In a behind-the-scenes look at a pharmaceutical company, we hear the background stories of both Mr. Huff and Dr. Meyer, as well as the origin of Reata.

One of our guests divulges that he owns a Viper and races cars. Listen to find out which one Sean is jealous of.

We also ask them about a new drug that Reata is developing, called RTA-408. This drug has special interest to us because it is a drug for patients with FA, which both Kyle and Sean have.

For more information on participating in MOXIe, Reata’s study in FA, visit http://www.curefa.org/clinical-trials/clinical-trials-active-enrollment-closed/cohort-9-moxie-phase-2-study-of-rta-408

On Sunday, February 25, the Dudes will be participating in Rare Disease Week, and this kicks off with a screening of the documentary The Ataxian, followed by a Q&A session. This starts at [5:30] at the Naval Heritage Center in Washing DC. If you’re nearby, we’d love to see you! For more info and to register, click here.